The primary aim of this work was to establish the gain-of-function effects from the (G4C2)n repeat expansion independent of the C9ORF72 gene context, and thereby identify potential therapeutic targets for C9ORF72-ALS. The gene discussed is C9orf72; the disease is amyotrophic lateral sclerosis.